These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12798515)

  • 21. Recombinant FVIIa.
    Hedner U
    Vox Sang; 2004 Jul; 87 Suppl 2():25-8. PubMed ID: 15209873
    [No Abstract]   [Full Text] [Related]  

  • 22. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
    Zver S; Andoljsek D; Cernelc P
    Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of recombinant factor VIIa in a patient with essential thrombocythaemia with uncontrolled surgical bleeding.
    Cervera JS; Mena-Durán AV; Piqueras CS
    Thromb Haemost; 2005 Feb; 93(2):383-4. PubMed ID: 15711760
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a high thrombosis rate associated with recombinant factor VIIa use in intractable hemorrhage in Australia?
    Dunkley S; Street A
    J Thromb Haemost; 2004 Oct; 2(10):1852-3. PubMed ID: 15456504
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant activated factor VII for non-hemophiliac bleeding patients.
    Uhlmann EJ; Eby CS
    Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
    Hoffman R; Eliakim R; Zuckerman T; Rowe JM; Brenner B
    J Thromb Haemost; 2003 Mar; 1(3):606-8. PubMed ID: 12871480
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage: a survey of current UK practice.
    Biss TT; Hanley JP
    Br J Haematol; 2007 Jul; 138(1):126-8. PubMed ID: 17555457
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
    Dhruva KK; Joel VD; Antony S; Vinodan K
    J Indian Med Assoc; 2006 Jan; 104(1):42, 44. PubMed ID: 16850866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of bleeding using recombinant factor VIIa in a patient suffering from bleeding tendency due to a lupus anticoagulant-hypoprothrombinemia syndrome.
    Holm M; Andreasen R; Ingerslev J
    Thromb Haemost; 1999 Dec; 82(6):1776-8. PubMed ID: 10613675
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
    Poon MC
    Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
    Al Hammadi AM; Sallah S
    J Thromb Haemost; 2007 Feb; 5(2):435-6. PubMed ID: 17269940
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of recombinant factor VIIa for bleeding in paediatric practice.
    Millar CG; Stringer MD; Sugarman I; Richards M
    Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant activated factor VIIa (rFVIIa) in intractable haemorrhage: use of a clinical scoring system.
    Pugh R; Wenstone R; Goh N
    Vox Sang; 2006 May; 90(4):331; author reply 332. PubMed ID: 16635077
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
    Grinţescu I; Tulbure D; Mirea L
    Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.